Researchers have developed a blood test for ALS that, when used alongside standard clinical evaluations, can accurately and rapidly diagnose the disease. The test can distinguish ALS from other neurologic conditions with nearly 100% accuracy. The unique fingerprint of microRNA taken from a standard blood draw accurately identifies ALS patients at early stages. This blood biomarker test could reduce diagnostic delays and improve disease outcomes, allowing for earlier use of disease-modifying ALS drugs. The test has been patented and discussions with commercial diagnostic firms are underway to make it available after FDA approval. Experts believe this test could be a breakthrough in diagnosing ALS earlier and improving treatment outcomes.
Source link
ALS Blood Test Promises Accurate, Earlier Diagnosis
